Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Allocated Share-based Compensation Expense	$ 10,321	$ 6,878	$ 2,414
Cost of revenue [Member]
Allocated Share-based Compensation Expense	125	72	27
Research, development and clinical trials expenses [Member]
Allocated Share-based Compensation Expense	1,465	1,114	396
Selling, general and administrative expenses [Member]
Allocated Share-based Compensation Expense	$ 8,731	$ 5,692	$ 1,991